XML 34 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Distribution Agreement
12 Months Ended
Jun. 30, 2014
Equity [Abstract]  
Distribution Agreement

10.Distribution Agreement

 

The Company has the exclusive distribution rights, through MPLA, to distribute, market, promote, detail, advertise and sell certain Licensed Products, with metallo-polypeptide analgesic as an active ingredient, in the United States (excluding its territories and possessions) (Note 1). If, and when necessary, the Company will obtain all necessary regulatory approvals for the Licensed Products and incorporate the Licensed Products in the United States.